OPKO Health (MEX:OPK) FCF Margin % : -48.96% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is OPKO Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OPKO Health's Free Cash Flow for the three months ended in Sep. 2024 was MXN-1,674 Mil. OPKO Health's Revenue for the three months ended in Sep. 2024 was MXN3,419 Mil. Therefore, OPKO Health's FCF Margin % for the quarter that ended in Sep. 2024 was -48.96%.

As of today, OPKO Health's current FCF Yield % is -18.46%.

The historical rank and industry rank for OPKO Health's FCF Margin % or its related term are showing as below:

MEX:OPK' s FCF Margin % Range Over the Past 10 Years
Min: -104.38 Med: -8.54 Max: 30.13
Current: -28.69

During the past 13 years, the highest FCF Margin % of OPKO Health was 30.13%. The lowest was -104.38%. And the median was -8.54%.

MEX:OPK's FCF Margin % is ranked worse than
65.28% of 216 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.655 vs MEX:OPK: -28.69

OPKO Health FCF Margin % Historical Data

The historical data trend for OPKO Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health FCF Margin % Chart

OPKO Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-20.54

0.40

0.35

-11.93

-5.15

OPKO Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															16.19	-22.71	-23.04	-18.47	-48.96

Competitive Comparison of OPKO Health's FCF Margin %

For the Diagnostics & Research subindustry, OPKO Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OPKO Health's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OPKO Health's FCF Margin % falls into.

OPKO Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OPKO Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-754.879	/	14657.178
	=	-5.15 %

OPKO Health's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-1673.991	/	3418.866
	=	-48.96 %

OPKO Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of OPKO Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

OPKO Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (MEX:OPK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OPK:USA OPK:Israel 0KCS:UK XCY:Germany

Address

4400 Biscayne Boulevard, Miami, FL, USA, 33137

Website

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.